<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="https://www.joseph.larmarange.net/spip.php?id_mot=11&amp;page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange</title>
		<url>https://www.joseph.larmarange.net/local/cache-vignettes/L144xH52/joseph_larmarange_site-6e82f.svg?1649686173</url>
		<link>https://joseph.larmarange.net/</link>
		<height>52</height>
		<width>144</width>
	</image>



<item xml:lang="fr">
		<title>Pr&#233;sence &#224; l'AFRAVIH 2026</title>
		<link>https://www.joseph.larmarange.net/presence-a-l-afravih-2026</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/presence-a-l-afravih-2026</guid>
		<dc:date>2026-05-11T15:25:43Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>France</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>BESO</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Contraception</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>In&#233;galit&#233;s raciales</dc:subject>
		<dc:subject>Interdisciplinarit&#233;</dc:subject>
		<dc:subject>Intersectorialit&#233;</dc:subject>
		<dc:subject>Jeunes</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>&#201;ducation sexuelle</dc:subject>

		<description>
&lt;p&gt;13&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes, Lausanne, 4 au 7&#160;mai 2026, https://afravih2026.org. &lt;br class='autobr' /&gt; S'informer sur la sant&#233; sexualit&#233; et la sexualit&#233;&#160;: quelles donn&#233;es&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? comment les jeunes y acc&#232;dent-ils&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? quel acc&#232;s &#224; une &#233;ducation sexuelle compl&#232;te et compr&#233;hensive&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? &lt;br class='autobr' /&gt; Joseph Larmarange 13&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-France-+" rel="tag"&gt;France&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-beso-+" rel="tag"&gt;BESO&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-inegalites-raciales-+" rel="tag"&gt;In&#233;galit&#233;s raciales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-interdisciplinarite-+" rel="tag"&gt;Interdisciplinarit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-intersectorialite-+" rel="tag"&gt;Intersectorialit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Jeunes-+" rel="tag"&gt;Jeunes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-education-sexuelle-+" rel="tag"&gt;&#201;ducation sexuelle&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/IMG/logo/afravih-2026-scaled.webp?1778510599' class='spip_logo spip_logo_right' width='150' height='41' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;13&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes, Lausanne, 4 au 7&#160;mai 2026, &lt;a href=&#034;https://afravih2026.org&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;https://afravih2026.org&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619079&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619079v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619079v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;S'informer sur la sant&#233; sexualit&#233; et la sexualit&#233; : quelles donn&#233;es ? comment les jeunes y acc&#232;dent-ils ? quel acc&#232;s &#224; une &#233;ducation sexuelle compl&#232;te et compr&#233;hensive ?&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, AFRAVIH, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619079v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619079&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619120&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619112v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-1697f54f-033f0.png?1778696180' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619112v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;PrEP : perceptions et ressentis des potentiels utilisateurs&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, AFRAVIH, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619112v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619112&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
En lien avec le projet PRINCESSE&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619133&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619133v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619133v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Enjeux de la mise en &#339;uvre de la PrEP aupr&#232;s d'une population pr&#233;caire, mobile et vuln&#233;rable : le&#231;ons du projet ANRS 12381 PRINCESSE aupr&#232;s de travailleuses du sexe en C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, AFRAVIH, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619133v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619133&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619143&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619143v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619143v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Facteurs de maintien et obstacles &#224; l'engagement des &#233;ducatrices de paires aupr&#232;s des travailleuses du sexe sur le projet ANRS 12381 PRINCESSE en C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, AFRAVIH, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619143v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619143&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
En lien avec le projet BESO&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5619157&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05619157v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619157v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Repenser la mesure des pratiques pr&#233;ventives : l'exemple des besoins non couverts en sant&#233; sexuelle &#224; partir de l'enqu&#234;te CSF 2023&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;13e conf&#233;rence francophone AFRAVIH sur le VIH, les h&#233;patites virales, la sant&#233; sexuelle et les infections &#233;mergentes&lt;/i&gt;, May 2026, Lausanne, Suisse&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05619157v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05619157&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>BESO - Besoins de pr&#233;vention en sant&#233; sexuelle non couverts selon l'origine&#160;: approche intersectionnelle et impact des discriminations</title>
		<link>https://www.joseph.larmarange.net/beso-besoins-de-prevention-en</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/beso-besoins-de-prevention-en</guid>
		<dc:date>2026-03-01T16:08:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>France</dc:subject>
		<dc:subject>BESO</dc:subject>
		<dc:subject>Contraception</dc:subject>
		<dc:subject>In&#233;galit&#233;s de genre</dc:subject>
		<dc:subject>Intersectorialit&#233;</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Pr&#233;carit&#233;</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>In&#233;galit&#233;s raciales</dc:subject>
		<dc:subject>Discriminations / Stigmatisation</dc:subject>

		<description>
&lt;p&gt;Responsable scientifique COULIBALY Karna &lt;br class='autobr' /&gt;
Membres du Ceped participant au projet COULIBALY Karna (Post-doctorants et Jeunes chercheurs) LARMARANGE Joseph (Chercheurs, Enseignants-Chercheurs, Ing&#233;nieurs) &lt;br class='autobr' /&gt;
Financements ANRS | MIE LIEPP Sciences Po - IdEx Universit&#233; Paris Cit&#233; (ANR-18-IDEX-0001) &lt;br class='autobr' /&gt;
Partenaires Centre Population et D&#233;veloppement Institut national de la sant&#233; et de la recherche m&#233;dicale (Inserm) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; http://www.inserm.fr &#201;quipe de l'enqu&#234;te Contexte des sexualit&#233;s en France (CSF&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Projets-de-Recherche-" rel="directory"&gt;Projets de Recherche&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-France-+" rel="tag"&gt;France&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-beso-+" rel="tag"&gt;BESO&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Contraception-+" rel="tag"&gt;Contraception&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Inegalites-de-genre-+" rel="tag"&gt;In&#233;galit&#233;s de genre&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-intersectorialite-+" rel="tag"&gt;Intersectorialit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Precarite-+" rel="tag"&gt;Pr&#233;carit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-inegalites-raciales-+" rel="tag"&gt;In&#233;galit&#233;s raciales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-discriminations-stigmatisation-+" rel="tag"&gt;Discriminations / Stigmatisation&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH82/gemini_generated_image_4sp0ot4sp0ot4sp0-08186.png?1778512089' class='spip_logo spip_logo_right' width='150' height='82' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Responsable scientifique&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; COULIBALY Karna&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Membres du Ceped participant au projet&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; COULIBALY Karna (Post-doctorants et Jeunes chercheurs)&lt;/li&gt;&lt;li&gt; LARMARANGE Joseph (Chercheurs, Enseignants-Chercheurs, Ing&#233;nieurs)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Financements&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; ANRS | MIE&lt;/li&gt;&lt;li&gt; LIEPP Sciences Po - IdEx Universit&#233; Paris Cit&#233; (ANR-18-IDEX-0001)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Partenaires&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Centre Population et D&#233;veloppement&lt;/li&gt;&lt;li&gt; Institut national de la sant&#233; et de la recherche m&#233;dicale (Inserm) &lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt; &lt;a href=&#034;http://www.inserm.fr&#034; class=&#034;spip_url spip_out auto&#034; rel=&#034;nofollow external&#034;&gt;http://www.inserm.fr&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &#201;quipe de l'enqu&#234;te Contexte des sexualit&#233;s en France (CSF 2023)&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233; &lt;/h2&gt;
&lt;p&gt;Les derni&#232;res d&#233;cennies ont &#233;t&#233; marqu&#233;es par d'importants progr&#232;s en mati&#232;re de prise en charge et de pr&#233;vention des probl&#233;matiques de sant&#233; sexuelle. L'offre de pr&#233;vention du VIH, des IST et des grossesses non souhait&#233;es s'est diversifi&#233;e afin de r&#233;pondre aux diff&#233;rents besoins de pr&#233;vention des personnes expos&#233;es. Cependant, les donn&#233;es &#233;pid&#233;miologiques r&#233;v&#232;lent la persistance de nouvelles infections par le VIH, des IST bact&#233;riennes ainsi que des cas de grossesses non souhait&#233;es.&lt;/p&gt;
&lt;p&gt;Ces constats soulignent l'existence de besoins de pr&#233;vention en sant&#233; sexuelle non couverts c'est-&#224;-dire le fait d'&#234;tre expos&#233; &#224; des risques en sant&#233; sexuelle sans recourir aux m&#233;thodes de pr&#233;vention disponibles. La question des besoins de pr&#233;vention en sant&#233; sexuelle non couverts constitue ainsi un enjeu majeur de pr&#233;vention en sant&#233; sexuelle. Cependant, sa mesure reste complexe. D'une part, parce qu'elle suppose de pouvoir identifier les expositions en sant&#233; sexuelle au niveau individuel et les m&#233;thodes adapt&#233;es &#224; chaque exposition. Or, les diff&#233;rents outils de pr&#233;vention ne prot&#232;gent pas tous des m&#234;mes risques et tous les individus n'ont pas forc&#233;ment un besoin pr&#233;ventif. D'autre part, sa mesure exige de disposer de donn&#233;es de grande ampleur qui portent sur toutes les populations, qui couvrent les expositions et interrogent le recours aux m&#233;thodes pr&#233;ventives. Ce type d'enqu&#234;te est pourtant rare en France. Ce projet de recherche a pour objectif principal d'&#233;tudier &#224; partir des donn&#233;es de l'enqu&#234;te Contexte des Sexualit&#233;s en France (CSF 2023), une enqu&#234;te nationale repr&#233;sentative des populations de 15 &#224; 89 ans vivant en France &#8211; comment mesurer les besoins de pr&#233;vention en sant&#233; sexuelle non couverts&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? Cette r&#233;flexion est abord&#233;e &#224; partir des besoins de pr&#233;vention non couverts li&#233;s au VIH, aux IST bact&#233;riennes et aux grossesses non souhait&#233;es. Ce projet vise des comparaisons selon l'origine pour mettre en lumi&#232;re les in&#233;galit&#233;s en sant&#233; sexuelle qui existent entre les populations selon leur origine et &#233;tudier leurs d&#233;terminants. &lt;br class='autobr' /&gt;
Ce projet vise &#224;&#160;:&lt;/p&gt;
&lt;ol class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; d&#233;finir comment mesurer les besoins de pr&#233;vention en sant&#233; sexuelle non-couverts (VIH, IST bact&#233;riennes et grossesses non souhait&#233;es),&lt;/li&gt;&lt;li&gt; construire des indicateurs de mesure des besoins pr&#233;ventifs&#160;: absence de besoins, besoins couverts (et m&#233;thodes utilis&#233;es), besoins non couverts et analyser les diff&#233;rences de besoins de pr&#233;vention en sant&#233; sexuelle non couverts selon l'origine,&lt;/li&gt;&lt;li&gt; v&#233;rifier si les &#233;carts de besoins de pr&#233;vention en sant&#233; sexuelle non couverts selon l'origine se maintiennent apr&#232;s avoir pris en compte l'imbrication des rapports sociaux de genre, classe, race, d'orientation sexuelle&#8230;(approche bas&#233;e sur l'intersectionnalit&#233;),&lt;/li&gt;&lt;li&gt; examiner dans quelle mesure l'effet de l'origine sur les besoins de pr&#233;vention en sant&#233; sexuelle non couverts est m&#233;di&#233; par les discriminations subies. Cette recherche contribuera au d&#233;veloppement de nouvelles connaissances sur les besoins de pr&#233;vention de la population majoritaire, des immigr&#233;s, des descendants d'immigr&#233;s et des natifs des DOM.&#160;Elle permettra d'&#233;tudier les liens complexes entre origine, intersectionnalit&#233;, discrimination et besoins de pr&#233;vention en sant&#233; sexuelle.&lt;/li&gt;&lt;/ol&gt;&lt;h2 class=&#034;spip&#034;&gt;
Mots-Cl&#233;s &lt;/h2&gt;
&lt;p&gt;Sant&#233; Sexuelle, Besoins non couverts, Pr&#233;vention, VIH, IST, Grossesses non souhait&#233;es, Origine, Intersectionnalit&#233;, Discriminations.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Zones g&#233;ographiques (terrains de recherche)&lt;/h2&gt;
&lt;p&gt;France hexagonale et Outre-Mer&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Calendrier&lt;/h2&gt;
&lt;p&gt;2025 - 2027&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters</title>
		<link>https://www.joseph.larmarange.net/adoption-of-hiv-preexposure</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/adoption-of-hiv-preexposure</guid>
		<dc:date>2025-07-15T15:10:30Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Joseph Larmarange, M&#233;lanie Plazy, Marcellin Nouaman, Evelyne Kissi, Rose-Marcelle Dedocoton, Patrick Coffie, Serge Eholi&#233;, Valentine Becquet &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
BACKGROUND: The ANRS 12381 PRINCESSE project (11/2019-06/2023) enrolled 489 FSWs and implemented community-based sexual and reproductive health care, including PrEP, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims to describe PrEP trajectories and the factors associated with&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L86xH150/ias2025-a9891.png?1752596042' class='spip_logo spip_logo_right' width='86' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5163756&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05163730v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH43/thumb-1a4ce10f-3d2ff.png?1752686173' alt=&#034;Image document&#034; width='75' height='43' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163730v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;IAS 2025, the 13th IAS Conference on HIV Science&lt;/i&gt;, International AIDS Society, Jul 2025, Kigali, Rwanda&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163730v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05163730&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, M&#233;lanie Plazy, Marcellin Nouaman, Evelyne Kissi, Rose-Marcelle Dedocoton, Patrick Coffie, Serge Eholi&#233;, Valentine Becquet&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;BACKGROUND:&lt;/strong&gt; The ANRS 12381 PRINCESSE project (11/2019-06/2023) enrolled 489 FSWs and implemented community-based sexual and reproductive health care, including PrEP, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims to describe PrEP trajectories and the factors associated with its use, focusing on &#8220;early adopters&#8221;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;METHODS:&lt;/strong&gt; This analysis included 400 FSWs eligible for PrEP (HIV-negative, HBsAg-negative) enrolled up to December 2022 (&gt;6 months of follow-up). Clinical records were analyzed to describe PrEP cascade, follow-up, and PrEP trajectories. A multivariable logistic regression identified factors associated with PrEP early adopters.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;RESULTS:&lt;/strong&gt; Although 98% of eligible FSWs were interested in PrEP, only 62% initiated PrEP, and 39% renewed it at least once.&lt;br class='autobr' /&gt;
Follow-up was very short (&lt;6 months) for 48%, short (6-12 months) for 15%, seasonal (&gt;12 months with a gap of 6 months between two visits) for 31%, and regular (&gt;12 months with no gap) for 6%.&lt;br class='autobr' /&gt;
PrEP initiation was high among FSWs with regular (96%), seasonal (83%), or short (80%) follow-up, vs. 39% for those with very short follow-up. Among those who initiated, only 88% (regular), 70% (seasonal), 74% (short), and 35% (very short) renewed PrEP.&lt;br class='autobr' /&gt;
Among 148 FSWs with regular/seasonal follow-up, four PrEP trajectories were identified (cf. figure showing individual trajectories): 15% &#8220;never initiated&#8221; PrEP, 39% &#8220;initiated and were later not interested anymore&#8221;, 18% &#8220;re-initiated after non-interest&#8221;, and 28% &#8220;initiated and never expressed non-interest&#8221;, the last two groups being considered as &#8220;early adopters&#8221;. Factors associated with early PrEP adoption included the usual price of intercourse with clients &lt;1500 FCFA (aOR=2.4 [1.2-4.8]) and working in brothels (aOR=3.2 [1.6-6.6]).&lt;/p&gt;
&lt;dl class='spip_document_627 spip_documents spip_documents_center media media_vignette'&gt; &lt;dt&gt;&lt;a href='https://www.joseph.larmarange.net/IMG/png/figure_1000.png' class=&#034;spip_in&#034; title=&#034;Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project&#034; hreflang=&#034;&#034; type=&#034;image/png&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L240xH360/figure_1000-140af-7601a.png?1752596042' width='240' height='360' alt='Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project' /&gt;&lt;/a&gt;&lt;/dt&gt; &lt;dt class='spip_doc_titre crayon document-titre-627' style='max-width: 240px;'&gt;&lt;strong&gt;Figure presenting individual PrEP trajectories of FSWs enrolled in the PRINCESSE project&lt;/strong&gt;&lt;/dt&gt;&lt;/dl&gt;
&lt;p&gt;&lt;strong&gt;CONCLUSIONS:&lt;/strong&gt; In PRINCESSE, loss-to-follow-up and seasonality of risks limited PrEP adoption. FSWs who were more precarious and less mobile became early adopters of this new prevention tool and could serve as potential ambassadors for promoting its uptake.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
See also&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5163769&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05163769v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163769v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Perceptions regarding long-acting pre-exposure prevention (PrEP) among female sex workers and men having sex with men in San Pedro and Abidjan, C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;IAS 2025, the 13th IAS Conference on HIV Science&lt;/i&gt;, Jul 2025, Kigali, Rwanda. &lt;a target=&#034;_blank&#034; href=&#034;https://programme.ias2025.org/Abstract/Abstract/?abstractid=4762&#034; rel=&#034;noreferrer noopener&#034;&gt;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05163769v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05163769&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition: An Individual Participant Data Meta-Analysis of the CohMSM, HPTN 075, and Anza Mapema Cohort Studies in Africa</title>
		<link>https://www.joseph.larmarange.net/the-effect-of-sexual-and-gender</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/the-effect-of-sexual-and-gender</guid>
		<dc:date>2025-07-15T14:38:37Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; mentale</dc:subject>
		<dc:subject>Violences</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
James Stannah, Jesse Knight, Theo Sandfort, Christian Laurent, Fredrick O. Otieno, Joseph Larmarange, Pierre-Julien Coulaud, Victor Mudhune, erica hamilton, Vanessa Cummings, Bruno Spire, Doerieyah Reynolds, Sufia Dadabhai, Duncan Okall, Bintou Demb&#233;l&#233; Keita, Luis Sagaon-Teyssier, Ravindre Panchia, Marie-Claude Boily &amp; Mathieu Maheu-Giroux &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Some sexual and gender minorities (SGM), including men who have sex with men and transgender women, are disproportionately&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-sante-mentale-+" rel="tag"&gt;Sant&#233; mentale&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-violences-+" rel="tag"&gt;Violences&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L100xH150/pexels-anna-shevchuk-197095787-11503175-c6607.jpg?1752595245' class='spip_logo spip_logo_right' width='100' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5161352&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05161352v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L58xH75/thumb-0374ae08-cda1b.png?1752595245' alt=&#034;Image document&#034; width='58' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05161352v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition: An Individual Participant Data Meta-Analysis of the CohMSM, HPTN 075, and Anza Mapema Cohort Studies in Africa&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=James+Stannah&#034; class=&#034;hal-auteur&#034;&gt;James Stannah&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Jesse+Knight&#034; class=&#034;hal-auteur&#034;&gt;Jesse Knight&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Theo+Sandfort&#034; class=&#034;hal-auteur&#034;&gt;Theo Sandfort&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731241921&#034; class=&#034;hal-auteur&#034;&gt;Christian Laurent&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Fredrick+Otieno&#034; class=&#034;hal-auteur&#034;&gt;Fredrick Otieno&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/pierre-julien-coulaud&#034; class=&#034;hal-auteur&#034;&gt;Pierre-Julien Coulaud&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Victor+Mudhune&#034; class=&#034;hal-auteur&#034;&gt;Victor Mudhune&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Erica+Hamilton&#034; class=&#034;hal-auteur&#034;&gt;Erica Hamilton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Vanessa+Cummings&#034; class=&#034;hal-auteur&#034;&gt;Vanessa Cummings&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Bruno+Spire&#034; class=&#034;hal-auteur&#034;&gt;Bruno Spire&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Doerieyah+Reynolds&#034; class=&#034;hal-auteur&#034;&gt;Doerieyah Reynolds&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Sufia+Dadabhai&#034; class=&#034;hal-auteur&#034;&gt;Sufia Dadabhai&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Duncan+Okall&#034; class=&#034;hal-auteur&#034;&gt;Duncan Okall&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Bintou+Demb%C3%A9l%C3%A9+Keita&#034; class=&#034;hal-auteur&#034;&gt;Bintou Demb&#233;l&#233; Keita&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/luis-sagaon-teyssier&#034; class=&#034;hal-auteur&#034;&gt;Luis Sagaon-Teyssier&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ravindre+Panchia&#034; class=&#034;hal-auteur&#034;&gt;Ravindre Panchia&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marie-Claude+Boily&#034; class=&#034;hal-auteur&#034;&gt;Marie-Claude Boily&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197203&#034; class=&#034;hal-auteur&#034;&gt;Mathieu Maheu-Giroux&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;AIDS and Behavior&lt;/i&gt;, 2025, &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1007/s10461-025-04799-4&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1007/s10461-025-04799-4&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05161352v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05161352&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;James Stannah, Jesse Knight, Theo Sandfort, Christian Laurent, Fredrick O. Otieno, Joseph Larmarange, Pierre-Julien Coulaud, Victor Mudhune, erica hamilton, Vanessa Cummings, Bruno Spire, Doerieyah Reynolds, Sufia Dadabhai, Duncan Okall, Bintou Demb&#233;l&#233; Keita, Luis Sagaon-Teyssier, Ravindre Panchia, Marie-Claude Boily &amp; Mathieu Maheu-Giroux&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;Some sexual and gender minorities (SGM), including men who have sex with men and transgender women, are disproportionately vulnerable to HIV. Many SGM in Africa report experiencing verbal or physical violence due to their sexual and/or gender identities or behaviours. The pathways linking such SGM violence to HIV acquisition are complex. We described experiences of verbal and physical SGM violence and explored pathways to HIV acquisition among SGM assigned male sex at birth using a two-stage individual participant data meta-analysis of three African cohort studies: CohMSM (Burkina Faso, C&#244;te d'Ivoire, Mali, Togo), HPTN 075 (Kenya, Malawi, South Africa), and Anza Mapema (Kenya). SGM violence was assessed at baseline and follow-up visits. We fit log-linear sequential conditional mean models using generalised estimating equations to estimate risk ratios linking SGM violence, moderate-to-severe depressive symptoms, hazardous drinking, condom use, and HIV acquisition, adjusted for baseline confounders and previous exposure and outcome. We pooled study estimates using random effects meta-analysis. SGM violence, mostly verbal, was reported by 36% (570/1590) participants at baseline (past 6&#8211;12 months), and 20% (321/1590) during the first year of follow-up (past 3&#8211;6 months). Baseline SGM violence was not associated with HIV acquisition (pooled adjusted risk ratio [aRR]&#8201;=&#8201;1.0, 95% CI 0.5&#8211;1.9). During follow-up, SGM violence also showed no clear relationship with HIV, but was linked to depressive symptoms at the same visit (pooled aRR&#8201;=&#8201;1.7, 1.3&#8211;2.1), in turn associated with hazardous drinking (pooled aRR&#8201;=&#8201;1.4, 1.1&#8211;1.7). Impacts on condom use were inconclusive. SGM in Africa face high rates of violence, which are associated with depressive symptoms and hazardous drinking&#8211;potential routes to HIV vulnerability. While our study did not conclusively demonstrate higher HIV incidence among SGM reporting violence, interventions to reduce violence and support mental health remain crucial.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>ANRS 12381 PRINCESSE @ AIDSImpact 2025: PrEP adoption &amp; perceptions of long acting PrEP</title>
		<link>https://www.joseph.larmarange.net/anrs-12381-princesse-aidsimpact</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/anrs-12381-princesse-aidsimpact</guid>
		<dc:date>2025-05-30T14:21:01Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Repr&#233;sentations / Perceptions</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters &lt;br class='autobr' /&gt;
Introduction &lt;br class='autobr' /&gt;
The ANRS 12381 PRINCESSE project (November 2019 - June 2023) implemented community-based sexual and reproductive health care, including preexposure prophylaxis (PrEP), for female sex workers (FSWs) in the San Pedro region of C&#244;te d'Ivoire, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representations-Perceptions-+" rel="tag"&gt;Repr&#233;sentations / Perceptions&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH55/aidsimpact2025logo-047e2.png?1748616898' class='spip_logo spip_logo_right' width='150' height='55' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5090841&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05090841v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090841v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;16th AIDSImpact Conference&lt;/i&gt;, AIDSImpact, May 2025, Casablanca, Morocco&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090841v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05090841&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Adoption of HIV preexposure prophylaxis (PrEP) among female sex workers (FSWs) in C&#244;te d'Ivoire: complex trajectories and early adopters&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The ANRS 12381 PRINCESSE project (November 2019 - June 2023) implemented community-based sexual and reproductive health care, including preexposure prophylaxis (PrEP), for female sex workers (FSWs) in the San Pedro region of C&#244;te d'Ivoire, delivered through mobile clinics at prostitution sites in the San Pedro region. This presentation aims to describe PrEP trajectories and the factors associated with its use, focusing on &#8220;early adopters&#8221;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;A total of 489 women were enrolled in the PRINCESSE cohort. This analysis included 400 FSWs eligible for PrEP (HIV-negative, HBsAg-negative at baseline) enrolled up to December 2022 (i.e. enrolled at least 6 months before cohort closure). Clinical records were analyzed to describe PrEP cascade, follow-up, and PrEP trajectories. A multivariable logistic regression identified factors associated with PrEP early adopters.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The overall PrEP cascade showed that although 98% of eligible FSWs were interested in PrEP, only 62% initiated PrEP, and 39% renewed it at least once.&lt;/p&gt;
&lt;p&gt;Follow-up was very short (&lt;6 months) for 48% of FSWs, short (6-12 months) for 15%, seasonal (&gt;12 months with a gap of 6 months between two visits) for 31%, and regular (&gt;12 months with no gap) for 6%.&lt;/p&gt;
&lt;p&gt;PrEP initiation was high among FSWs with regular (96%), seasonal (83%), or short (80%) follow-up, vs. 39% for those with very short follow-up. Among those who initiated, only 88% (regular), 70% (seasonal), 74% (short), and 35% (very short) renewed PrEP.&lt;/p&gt;
&lt;p&gt;Among 148 FSWs with regular/seasonal follow-up, four PrEP trajectories were identified (cf. attached figure showing individual trajectories, each line representing a participant's PrEP journey): 15% never initiated PrEP; 39% initiated PrEP before stopping and expressing they were not interested anymore; 18% re-initiated PrEP after an episode of non-interest&#8221;; and 28% initiated and never expressed non-interest at a later stage. The last two groups were considered as &#8220;early adopters&#8221;. Significant factors associated with early PrEP adoption were the usual price of intercourse with clients &lt;1500 FCFA (i.e. 2.3 EUR) (aOR=2.4 [1.2-4.8]) and working in brothels (aOR=3.2 [1.6-6.6]).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;In PRINCESSE, loss-to-follow-up and seasonality of risks limited PrEP adoption. FSWs who were more precarious and less mobile became early adopters of this new prevention tool and could serve as potential ambassadors for promoting its uptake and demand creation.&lt;/p&gt;
&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5090784&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05090784v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090784v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Perception de la Prophylaxie pr&#233;exposition &#224; longue dur&#233;e d'action chez les travailleuses du sexe et les HSH &#224; San Pedro et Abidjan, C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;16th AIDSImpact Conference&lt;/i&gt;, AIDSImpact, May 2025, Casablanca, Maroc&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05090784v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05090784&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div lang='fr'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Perception de la Prophylaxie pr&#233;exposition &#224; longue dur&#233;e d'action chez les travailleuses du sexe et les HSH &#224; San Pedro et Abidjan, C&#244;te d'Ivoire&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&#160;:&lt;/strong&gt; Des recherches ont montr&#233; que l'utilisation et l'adh&#233;sion &#224; la PrEP par voie orale peuvent &#234;tre complexes au sein de certaines populations, telles que les travailleuses du sexe (TS) et les hommes ayant des relations sexuelles avec d'autres hommes (HSH), notamment en raison de leur grande mobilit&#233;, d'une vie quotidienne impr&#233;visible ou d'effets secondaires. Dans ce contexte, la PrEP &#224; longue dur&#233;e d'action (actuellement &#224; diff&#233;rents stades de d&#233;veloppement), telle que les injectables, le gel, les implants, les suppositoires vaginaux, les douches vaginales/anales ou les anneaux vaginaux, pourraient contribuer &#224; surmonter certaines difficult&#233;s rencontr&#233;es avec la PrEP orale. Cette &#233;tude visait &#224; explorer les perceptions de ces formulations &#224; longue dur&#233;e d'action parmi les TS et les HSH en C&#244;te d'Ivoire.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;M&#233;thodologie&#160;:&lt;/strong&gt; Inscrite dans le projet ANRS 12381 PRINCESSE, cette sous-&#233;tude qualitative a &#233;t&#233; men&#233;e en novembre-d&#233;cembre 2023 au sein de deux ONG communautaires&#160;: Aprosam &#224; San Pedro et Espace Confiance &#224; Abidjan aupr&#232;s des TS et HSH. Au total, 32 TS (19 na&#239;ves de PrEP et 13 exp&#233;riment&#233;es) et 12 HSH (3 na&#239;fs de PrEP et 9 exp&#233;riment&#233;s) ont &#233;t&#233; interrog&#233;s (lors de14 entretiens individuels et 5 focus groups). Une analyse th&#233;matique s'est concentr&#233;e sur l'aspect pratique, la discr&#233;tion, l'autonomie, l'efficacit&#233; per&#231;ue et les effets secondaires anticip&#233;s des diff&#233;rentes formulations de PrEP &#224; longue dur&#233;e d'action.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;R&#233;sultats&#160;:&lt;/strong&gt; Les participants ont g&#233;n&#233;ralement exprim&#233; des opinions favorables &#224; l'&#233;gard de la PrEP &#224; longue dur&#233;e d'action, consid&#233;r&#233;e comme une forme moins contraingrante que la PrEP par voie orale. Les injections ont &#233;t&#233; particuli&#232;rement appr&#233;ci&#233;es pour leur discr&#233;tion (pas de marque visible), les injections semestrielles &#233;tant pr&#233;f&#233;r&#233;es. Quelques inqui&#233;tudes ont &#233;t&#233; exprim&#233;es quant &#224; la douleur li&#233;e &#224; l'injection. Le gel, assimil&#233; &#224; un lubrifiant, a s&#233;duit par sa double fonction de protection et de plaisir. Toutefois, certains participants ont exprim&#233; des doutes quant &#224; son efficacit&#233;. Bien que la dur&#233;e d'action de l'implant (1 an) ait &#233;t&#233; appr&#233;ci&#233;e, elle n'a pas &#233;t&#233; pl&#233;biscit&#233;e en raison du manque de discr&#233;tion (cicatrice) et des effets secondaires potentiels anticip&#233;s. L'autonomie et la facilit&#233; d'utilisation des suppositoires vaginaux sont per&#231;ues comme avantageuses, &#224; condition que les conditions d'hygi&#232;ne soient optimales&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; les HSH font le parall&#232;le avec les suppositoires anaux. M&#234;me si les douches vaginales sont largement pratiqu&#233;es par les TS, la lotion de nettoyage intime de la PrEP a re&#231;u des r&#233;actions mitig&#233;es de la part des TS, conscientes des risques d'un usage excessif. Enfin, l'anneau vaginal a suscit&#233; peu d'int&#233;r&#234;t en raison de la m&#233;connaissance de l'outil.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion&#160;:&lt;/strong&gt; Dans l'ensemble, la PrEP &#224; longue dur&#233;e d'action peut offrir des options alternatives pour la pr&#233;vention du VIH. Les &#233;l&#233;ments cl&#233;s favorisant l'adoption &#224; un format (PrEP &#224; longue dur&#233;e d'action) sont la facilit&#233; d'utilisation, un suivi simplifi&#233; (le moins souvent possible), des r&#232;gles claires pour le d&#233;marrage et l'arr&#234;t, la discr&#233;tion, l'efficacit&#233; per&#231;ue et les effets secondaires anticip&#233;s.&lt;/p&gt;
&lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>La fin du sida est-elle toujours en vue&#160;?</title>
		<link>https://www.joseph.larmarange.net/la-fin-du-sida-est-elle-toujours</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/la-fin-du-sida-est-elle-toujours</guid>
		<dc:date>2025-03-27T10:47:15Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Pepfar</dc:subject>
		<dc:subject>Politiques publiques</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Science de la mise en &#339;uvre </dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;La fin du sida est-elle toujours en vue&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? &lt;br class='autobr' /&gt; Joseph Larmarange Journ&#233;e Scientifique Sidaction 2025, Sidaction, Mar 2025, Paris, France Communication dans un congr&#232;s hal-05008296 &lt;br class='autobr' /&gt;
Pl&#233;ni&#232;re d'ouverture de Journ&#233;e scientifique Sidaction 2025, le 27&#160;mars 2025 &#224; Paris.&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-pepfar-+" rel="tag"&gt;Pepfar&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Politiques-publiques-+" rel="tag"&gt;Politiques publiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-science-de-la-mise-en-oeuvre-+" rel="tag"&gt;Science de la mise en &#339;uvre &lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH100/pexels-xperimental-978844-10beb.jpg?1743072933' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5008311&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05008296v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05008296v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;La fin du sida est-elle toujours en vue ?&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Journ&#233;e Scientifique Sidaction 2025&lt;/i&gt;, Sidaction, Mar 2025, Paris, France&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05008296v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05008296&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;
&lt;p&gt;Pl&#233;ni&#232;re d'ouverture de &lt;a href=&#034;https://www.sidaction.org/action/soutenir-la-recherche/journee-scientifique-sidaction/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Journ&#233;e scientifique Sidaction 2025&lt;/a&gt;, le 27&#160;mars 2025 &#224; Paris.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/sidaction_larmarange_2025-03-27.pdf" length="3960097" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>VIH&#160;: des solutions pr&#233;ventives &#224; longue dur&#233;e prometteuses</title>
		<link>https://www.joseph.larmarange.net/vih-des-solutions-preventives-a</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/vih-des-solutions-preventives-a</guid>
		<dc:date>2024-12-02T17:58:04Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;La PrEP avec le l&#233;nacapavir injectable est une solution efficace et prometteuse pour les populations vuln&#233;rables, &#224; condition d'&#234;tre accessible. &lt;br class='autobr' /&gt;
Des outils de pr&#233;vention toujours plus efficaces et moins contraignants, adapt&#233;s aux conditions de vie et besoins r&#233;els des populations les plus expos&#233;es&#160;: voil&#224; le nerf de la guerre contre le VIH. Parmi eux, la PrEP avec le l&#233;nacapavir nourrit de grands espoirs comme outil de pr&#233;vention. Ce m&#233;dicament est d&#233;j&#224; utilis&#233; pour soigner les patients&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Divers-" rel="directory"&gt;Divers&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH56/img_20210903_124636_0-b22da.jpg?1733163509' class='spip_logo spip_logo_right' width='150' height='56' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4815260&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04815258v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-03b53679-98aa0.png?1733856007' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04815258v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;VIH : des solutions pr&#233;ventives &#224; longue dur&#233;e prometteuses&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Louise+Hurel&#034; class=&#034;hal-auteur&#034;&gt;Louise Hurel&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731241921&#034; class=&#034;hal-auteur&#034;&gt;Christian Laurent&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;2024&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-blog&#034;&gt;Article de blog scientifique&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04815258v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04815258&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;
&lt;p&gt;&lt;strong&gt;La PrEP avec le l&#233;nacapavir injectable est une solution efficace et prometteuse pour les populations vuln&#233;rables, &#224; condition d'&#234;tre accessible.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Des outils de pr&#233;vention toujours plus efficaces et moins contraignants, adapt&#233;s aux conditions de vie et besoins r&#233;els des populations les plus expos&#233;es&#160;: voil&#224; le nerf de la guerre contre le VIH. Parmi eux, la PrEP avec le l&#233;nacapavir nourrit de grands espoirs comme outil de pr&#233;vention. Ce m&#233;dicament est d&#233;j&#224; utilis&#233; pour soigner les patients ayant d&#233;velopp&#233; des r&#233;sistances aux traitements les plus courants. Deux &#233;tudes viennent de d&#233;montrer qu'il &#233;tait &#233;galement pleinement efficace pour emp&#234;cher les nouvelles infections, &#224; raison d'une injection sous-cutan&#233;e tous les six mois. Une r&#233;volution dans le domaine de la pr&#233;vention&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;!&lt;/p&gt;
&lt;p&gt;En quoi le l&#233;nacapavir injectable peut apporter une solution p&#233;renne&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? &#192; qui et sous quelles conditions&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;?&lt;/p&gt;
&lt;p&gt;Explications avec trois scientifiques impliqu&#233;s dans des projets de recherche aupr&#232;s de populations cl&#233;s&#160;: Christian Laurent, &#233;pid&#233;miologiste IRD &#224; TransVIHMI, coordinateur du projet CohMSM-PrEP, centr&#233; sur les hommes ayant des rapports sexuels avec les hommes (HSH) en Afrique de l'Ouest&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; Joseph Larmarange, d&#233;mographe IRD au Ceped, coordinateur du projet Princesse aupr&#232;s de travailleuses du sexe en C&#244;te d'Ivoire&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;; et Karna Coulibaly, d&#233;mographe Ined et chercheur associ&#233; au Ceped, impliqu&#233; dans le projet Makasi qui a &#233;t&#233; r&#233;alis&#233; aupr&#232;s d'immigr&#233;s d'Afrique subsaharienne en situation de pr&#233;carit&#233; vivant en &#206;le-de-France.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>PRINCESSE @ AIDS 2024 in Munich</title>
		<link>https://www.joseph.larmarange.net/princesse-aids-2024-in-munich</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/princesse-aids-2024-in-munich</guid>
		<dc:date>2024-07-23T15:46:03Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Pr&#233;carit&#233;</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; mentale</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Soignants / Professionnels de sant&#233;</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Pr&#233;carit&#233; menstruelle</dc:subject>

		<description>
&lt;p&gt;AIDS 2024, the 25&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; International AIDS Conference, was in Munich from 22 to 26&#160;July 2024. Four posters were selected on abstract. In addition, main results from the ANRS 12381 PRINCESSE project were presented and discussed on the stand France. &lt;br class='autobr' /&gt; Vulnerability and psychological distress of female sex workers in C&#244;te d'Ivoire &lt;br class='autobr' /&gt; Hasna Youssoufa , Marcelin N'Zebo Nouaman ,&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Precarite-+" rel="tag"&gt;Pr&#233;carit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-sante-mentale-+" rel="tag"&gt;Sant&#233; mentale&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-soignants-professionnels-de-sante-+" rel="tag"&gt;Soignants / Professionnels de sant&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-precarite-menstruelle-+" rel="tag"&gt;Pr&#233;carit&#233; menstruelle&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH38/aids-2024_patterns_8x2-d6413.png?1721752836' class='spip_logo spip_logo_right' width='150' height='38' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;AIDS 2024, the 25&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; International AIDS Conference, was in Munich from 22 to 26&#160;July 2024. Four posters were selected on abstract. In addition, main results from the ANRS 12381 PRINCESSE project were presented and discussed on the stand France.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4660382&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04660379v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-1e8f6d3d-ea404.png?1721932135' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04660379v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Vulnerability and psychological distress of female sex workers in C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Hasna+Youssoufa&#034; class=&#034;hal-auteur&#034;&gt;Hasna Youssoufa&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcelin+N%27Zebo+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcelin N'Zebo Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673846719&#034; class=&#034;hal-auteur&#034;&gt;Charlotte Bernard&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;AIDS 2024, the 25th International AIDS Conference&lt;/i&gt;, Jul 2024, Munich, Germany. &lt;a target=&#034;_blank&#034; href=&#034;https://programme.aids2024.org/Abstract/Abstract/?abstractid=7457&#034; rel=&#034;noreferrer noopener&#034;&gt;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04660379v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04660379&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4660392&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04660389v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-73f1e67b-8cce9.png?1721932135' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04660389v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;&#8216;Dirt just has to come down': body perceptions and lived experiences of female sex workers in C&#244;te d'Ivoire (ANRS 12361 PrEP-CI and ANRS 12381 PRINCESSE projects)&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcelin+N%27Zebo+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcelin N'Zebo Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;AIDS 2024, the 25th International AIDS Conference&lt;/i&gt;, Jul 2024, Munich, Germany. &lt;a target=&#034;_blank&#034; href=&#034;https://programme.aids2024.org/Abstract/Abstract/?abstractid=8529&#034; rel=&#034;noreferrer noopener&#034;&gt;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04660389v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04660389&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4660362&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04660360v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-0aee8703-d7768.png?1721932135' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04660360v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Facilitators and barriers to the enrolment and retention of female sex workers in a sexual health cohort (ANRS 12381 PRINCESSE) in San-Pedro, C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Evelyne+Kissi&#034; class=&#034;hal-auteur&#034;&gt;Evelyne Kissi&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Rose-Marcelle+Dedocoton&#034; class=&#034;hal-auteur&#034;&gt;Rose-Marcelle Dedocoton&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcelin+N%27Zebo+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcelin N'Zebo Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aline+Agoua&#034; class=&#034;hal-auteur&#034;&gt;Aline Agoua&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;AIDS 2024, the 25th International AIDS Conference&lt;/i&gt;, Jul 2024, Munich, Germany. &lt;a target=&#034;_blank&#034; href=&#034;https://programme.aids2024.org/Abstract/Abstract/?abstractid=5994&#034; rel=&#034;noreferrer noopener&#034;&gt;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04660360v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04660360&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4660371&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04660367v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-d74e53a7-8c118.png?1721932136' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04660367v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;&#8220;We used to treat a bit blindly: it was a syndromic diagnosis&#8221;. Physicians' perceptions of comprehensive management of sexually transmitted infections among sex workers in C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marcelin+N%27Zebo+Nouaman&#034; class=&#034;hal-auteur&#034;&gt;Marcelin N'Zebo Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731197957&#034; class=&#034;hal-auteur&#034;&gt;Serge Eholi&#233;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;AIDS 2024, the 25th International AIDS Conference&lt;/i&gt;, Jul 2024, Munich, Germany. &lt;a target=&#034;_blank&#034; href=&#034;https://programme.aids2024.org/Abstract/Abstract/?abstractid=6208&#034; rel=&#034;noreferrer noopener&#034;&gt;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-poster&#034;&gt;Poster de conf&#233;rence&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04660367v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04660367&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Transforming effective innovations into efficient interventions: contributions from social and implementation sciences</title>
		<link>https://www.joseph.larmarange.net/transforming-effective-innovations</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/transforming-effective-innovations</guid>
		<dc:date>2023-11-30T17:00:02Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Science de la mise en &#339;uvre </dc:subject>

		<description>
&lt;p&gt;Transforming effective innovations into efficient interventions: contributions from social and implementation sciences &lt;br class='autobr' /&gt; Joseph Larmarange 40 years of HIV science, Institut Pasteur; ANRS|MIE, Nov 2023, Paris, France Communication dans un congr&#232;s hal-04316678 Abstract &lt;br class='autobr' /&gt;
The history of the fight against AIDS has been marked by the development of major scientific and&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-science-de-la-mise-en-oeuvre-+" rel="tag"&gt;Science de la mise en &#339;uvre &lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L100xH150/pexels-karolina-grabowska-4207901-1c518.jpg?1715102645' class='spip_logo spip_logo_right' width='100' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4316684&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04316678v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04316678v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Transforming effective innovations into efficient interventions: contributions from social and implementation sciences&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;40 years of HIV science&lt;/i&gt;, Institut Pasteur; ANRS|MIE, Nov 2023, Paris, France&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04316678v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04316678&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;The history of the fight against AIDS has been marked by the development of major scientific and biomedical innovations: antiretroviral treatments, rapid screening tests, pre-exposure prophylaxis... However, these innovations have often been insufficient on their own to curve the epidemics. It has also been essential to innovate in terms of funding, organisation of services and care, advanced &#8220;out-of-hospital&#8221; strategies, human rights, taking account of the specific characteristics of the most vulnerable populations, etc.&lt;/p&gt;
&lt;p&gt;Effective innovation will be ineffective if it is not adapted to the social, cultural, and legal constraints faced by populations and to the structural, organisational, and economic constraints of healthcare systems. Hence the need for a genuine science of implementation that is necessarily interdisciplinary and intersectoral.&lt;/p&gt;
&lt;!--[if !IE]&gt;&lt;!--&gt;&lt;iframe src=&#034;spip.php?page=pdfjs&amp;id_document=584&#034; width=&#034;100%&#034; height=&#034;600&#034; title=&#034;Joseph Larmarange &#183; Transforming effective innovations into efficient interventions&#034; class=&#034;spip_document_584 lecteurpdf lecteufpdf-584 spip_documents&#034; name=&#034;pdf_584&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;!--&lt;![endif]--&gt; &lt;!--[if IE]&gt;&lt;iframe src=&#034;IMG/pdf/hiv_40_years_larmarange_v2023-11-30.pdf&#034; width=&#034;100%&#034; height=&#034;600&#034; class=&#034;spip_document_584 lecteurpdf lecteufpdf-584 spip_documents&#034; title=&#034;Joseph Larmarange &#183; Transforming effective innovations into efficient interventions&#034; name=&#034;pdf_584&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;![endif]--&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>PrEP among female sex workers: where are we? A literature review identifying knowledge gaps to guide the future research agenda</title>
		<link>https://www.joseph.larmarange.net/prep-among-female-sex-workers</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/prep-among-female-sex-workers</guid>
		<dc:date>2023-06-14T15:00:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Oral communication presented the 14&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; of June, 2023, at AIDS Impact conference in Stockholm, Sweden. &lt;br class='autobr' /&gt;
Authors &lt;br class='autobr' /&gt;
M&#233;lanie Plazy, Valentine Becquet, Esther Maouhoub, Carla Meertens, R&#233;mi Mouquin, Hasna Youssoufa, Marcellin Nouaman, Patrick Coffie, Joseph Larmarange &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Objectives. In 2015, the WHO recommended HIV pre-exposure prophylaxis (PrEP) for people at substantial risk of being infected by HIV, but also highlighted the need for research projects to improve PrEP implementation&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH113/the-pre-exposure-prophylaxis-drug-1200x900-85958.jpg?1715097925' class='spip_logo spip_logo_right' width='150' height='113' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Oral communication presented the 14&lt;sup&gt;th&lt;/sup&gt; of June, 2023, at &lt;a href=&#034;https://www.aidsimpact2023.com/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;AIDS Impact&lt;/a&gt; conference in Stockholm, Sweden.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4123476&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04120001v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04120001v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;PrEP among female sex workers: where are we? A literature review identifying knowledge gaps to guide the future research agenda&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/melanie-plazy&#034; class=&#034;hal-auteur&#034;&gt;M&#233;lanie Plazy&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Esther+Maouhoub&#034; class=&#034;hal-auteur&#034;&gt;Esther Maouhoub&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Carla+Meertens&#034; class=&#034;hal-auteur&#034;&gt;Carla Meertens&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Remi+Mouquin&#034; class=&#034;hal-auteur&#034;&gt;Remi Mouquin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Hasna+Youssoufa&#034; class=&#034;hal-auteur&#034;&gt;Hasna Youssoufa&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731196997&#034; class=&#034;hal-auteur&#034;&gt;Marcellin Nouaman&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673956000&#034; class=&#034;hal-auteur&#034;&gt;Patrick Coffie&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;AIDS Impact Conference&lt;/i&gt;, Jun 2023, Stockholm, Sweden&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04120001v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04120001&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;M&#233;lanie Plazy, Valentine Becquet, Esther Maouhoub, Carla Meertens, R&#233;mi Mouquin, Hasna Youssoufa, Marcellin Nouaman, Patrick Coffie, Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Objectives.&lt;/strong&gt; In 2015, the WHO recommended HIV pre-exposure prophylaxis (PrEP) for people at substantial risk of being infected by HIV, but also highlighted the need for research projects to improve PrEP implementation and follow-up, especially among female sex workers (FSW). While many studies have been published on PrEP among men who have sex with men, the literature is far less important among FSW. We aim to summarise the overall published literature on PrEP among FSW worldwide to display the challenges and facilitators of PrEP implementation in this population and highlight the knowledge gaps.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods.&lt;/strong&gt; We have conducted a systematic literature review searching Pubmed, Web of Sciences, Scopus, SocINDEX, APA PsycArticles, APA PsycInfo, Psychology and Behavioral Sciences Collection, until 31&#160;December 2022. All manuscripts on PrEP in FSW were included worldwide, regardless of the primary outcome, the type of PrEP (oral, topical or long-acting), the study design, or the type of data collection. Titles and abstracts were independently screened by three reviewers, and full texts by two reviewers. We excluded papers: not presenting specific or stratified results on FSW; study protocols; conference abstracts; not written in English or French. Two independent reviewers then reviewed each included study to extract: Unaids region, country, study type, outcomes (see description in the results), type of PrEP, and study years. The results of the included papers will be analysed in more detail by one reviewer for each type of outcome.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results.&lt;/strong&gt; Among the 412 published references identified through the search equation after duplicate removal, 198 were excluded based on the title and abstract, and 69 were excluded after full-text reading. Among the 145 papers included, n=10 were commentaries, n=17 literature reviews on global HIV prevention or including several populations, n=3 country case studies, n=24 modelling studies and n=91 other original papers. Among the latest, n=51 studies were conducted in Eastern and Southern Africa, n=13 in Western and Central Africa, n=11 in Asia and the Pacific, n=9 in Western and Central Europe and North America, n=7 in Latin America and the Caribbean; no studies were conducted in the Middle East and North Africa or Eastern Europe and Central Asia. The majority (n=85) were about oral PrEP. Regarding outcomes, n=39 were on knowledge/awareness, n=42 on willingness/interest, n=38 on attitudes/perceptions/beliefs, n=42 on uptake/use, n=21 on retention, n=23 on adherence, n=4 on efficacy/effectiveness, n=3 on epidemiological impacts, n=18 on behavioural impacts, n=5 on social impacts, n=10 on delivery models, n=9 on costs. Specific results for each type of outcome is in progress. Preliminary results suggest high PrEP willingness among FSW, but specific challenges regarding oral PrEP uptake and retention in this population.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Discussion.&lt;/strong&gt; The overall literature on PrEP focusing on FSW is relatively scarce (compared to more than 1850 references on PrEP among men who have sex with men identified on Pubmed by the end of 2022). The final results of this literature review will be available by May 2023. They will allow to guide the future research agenda regarding the implementation of biomedical HIV prevention among FSW.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>



</channel>

</rss>
